﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Sat, 04 Apr 2026 06:25:56 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/March-2025/rss/3105</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/March-2025/rss/3105" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Navigating career pathways and confidently switching paths]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/navigating-career-pathways-and-confidently-switching-paths</link><description><![CDATA[  Lauren Howell, PharmD  

   

 While job hopping may have once been considered a red flag or taboo, 21% of millennials report changing jobs in the past year, according to a Gallup report on ...]]></description><pubDate>Fri, 07 Feb 2025 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/navigating-career-pathways-and-confidently-switching-paths</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3070]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Dispensing error after confusion between Voxzogo dose and vial strength]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/dispensing-error-after-confusion-between-voxzogo-dose-and-vial-strength</link><description><![CDATA[  Institute for Safe Medication Practice, Horsham, PA  

   

 Voxzogo (vosoritide) is a C-type natriuretic peptide indicated to increase linear growth in pediatric patients with achondroplasia ...]]></description><pubDate>Fri, 07 Feb 2025 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/dispensing-error-after-confusion-between-voxzogo-dose-and-vial-strength</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3051]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Liability for warfarin overdose]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/liability-for-warfarin-overdose</link><description><![CDATA[  David B. Brushwood, BSPharm, JD  

   

 Arecent case from Illinois demonstrates, once again, how the instructions “as directed” in prescription vial labeling can invite malpractice liability. ...]]></description><pubDate>Fri, 07 Feb 2025 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/liability-for-warfarin-overdose</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3052]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[The difference between actual and potential revenue in a pharmacist-run ambulatory clinic]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/the-difference-between-actual-and-potential-revenue-in-a-pharmacist-run-ambulatory-clinic</link><description><![CDATA[  Lauren Howell, PharmD  

   

 A study from the November/December 2024 issue of  JAPhA  found that over a 3-month period, there was a difference of over $16,000 between the actual revenue that ...]]></description><pubDate>Fri, 07 Feb 2025 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/the-difference-between-actual-and-potential-revenue-in-a-pharmacist-run-ambulatory-clinic</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3053]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[FDA advisors recommend rescinding clozapine REMS]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/fda-advisors-recommend-rescinding-clozapine-rems</link><description><![CDATA[  Olivia C. Welter, PharmD  

   

 In November 2024, a joint FDA advisory committee voted 14–1 to eliminate the REMS program for clozapine. The advisory committee meeting included testimony from ...]]></description><pubDate>Fri, 07 Feb 2025 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/fda-advisors-recommend-rescinding-clozapine-rems</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3054]]></dc:identifier></item></channel></rss>